 | |
| Clinical data | |
|---|---|
| Other names | 4-Phenylbut-3-en-2-amine; 1-Methyl-3-phenylprop-2-enylamine; PAL-881/PAL-893 |
| Drug class | Norepinephrine–dopamine releasing agent[1][2] |
| Identifiers | |
| |
| PubChemCID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C10H13N |
| Molar mass | 147.221 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Phenylbutenamine, or4-phenylbut-3-en-2-amine, is amonoamine releasing agent (MRA) of thearylalkylamine family related toβ-phenethylamine andamphetamine.[1][2] It has two possiblestereoisomers: (3E)-phenylbutenamine (PAL-881) and (3Z)-phenylbutenamine (PAL-893).[1][2] Both of these enantiomers act asnorepinephrine–dopamine releasing agents (NDRAs), and to similar comparative extents, albeit with far lowerpotency than β-phenethylamine or amphetamine.[1][2][3]
 | Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it. |